Provided by Tiger Fintech (Singapore) Pte. Ltd.

INmune Bio Inc

1.79
-0.0250-1.38%
Volume:511.19K
Turnover:900.47K
Market Cap:47.45M
PE:-0.71
High:1.83
Open:1.83
Low:1.73
Close:1.81
52wk High:11.64
52wk Low:1.73
Shares:26.59M
Float Shares:20.18M
Volume Ratio:1.64
T/O Rate:2.53%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.5162
EPS(LYR):-2.1100
ROE:-168.34%
ROA:-55.08%
PB:1.64
PE(LYR):-0.85

Loading ...

INmune Bio Inc. Files Initial Beneficial Ownership Statement for Interim CFO Cory Randall Ellspermann

Reuters
·
Aug 19

INmune Bio Inc reports results for the quarter ended June 30 - Earnings Summary

Reuters
·
Aug 08

INmune Bio Q2 EPS $(1.05) Misses $(0.40) Estimate

Benzinga
·
Aug 08

INmune Bio Inc: Q2 EPS $-1.05

THOMSON REUTERS
·
Aug 08

INmune Bio Inc - Kelly Ganjei Appointed Chairman of the Board

THOMSON REUTERS
·
Aug 08

INmune Bio Inc - Cory Ellspermann Appointed Interim CFO

THOMSON REUTERS
·
Aug 08

INmune Bio Inc - David Moss Appointed President & CEO

THOMSON REUTERS
·
Aug 08

INmune Bio Inc: End of Phase 2 Meeting Regarding Mindful Trial With FDA Expected to Take Place in Q4

THOMSON REUTERS
·
Aug 08

INmune Bio Inc. Announces Second Quarter 2025 Results, Provides Business Update and Announces Management Changes

GlobeNewswire
·
Aug 08

INmune Bio Inc expected to post a loss of 38 cents a share - Earnings Preview

Reuters
·
Aug 06

BUZZ-U.S. STOCKS ON THE MOVE-Tyson Foods, BioNTech, Gold miners

Reuters
·
Aug 04

BUZZ-INmune Bio rises as prostate cancer therapy meets trial goals

Reuters
·
Aug 04

INmune Bio Announces Successful Completion of Phase I/II Trial for INKmune™ in Metastatic Castration-Resistant Prostate Cancer, Plans Phase 2b Trial

Reuters
·
Aug 04

INmune Bio’s Care PC Trial of Inkmune™ in Metastatic Castration-Resistant Prostate Cancer Meets Endpoints and Is Closed to Enrollment

THOMSON REUTERS
·
Aug 04

INmune Bio Inc - Inkmune Well Tolerated With Excellent Safety Profile

THOMSON REUTERS
·
Aug 04

INmune Bio Inc - Plans Phase 2B Trial for Less Severe Disease

THOMSON REUTERS
·
Aug 04